| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 97 |
| 1 | PENTOSAN POLYSULFATE SODIUM | 92 |
| 2 | AFLIBERCEPT | 73 |
| 3 | BEVACIZUMAB | 64 |
| 4 | ADALIMUMAB | 56 |
| 5 | DEXAMETHASONE | 55 |
| 6 | HYDROXYCHLOROQUINE | 52 |
| 7 | ASPIRIN | 49 |
| 8 | ASPIRIN 325 MG | 49 |
| 9 | ASPIRIN 81 MG | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORETIGENE NEPARVOVEC-RZYL | 15 | 0.0987 |
| 1 | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | 1 | 0.0370 |
| 2 | INAVOLISIB | 16 | 0.0239 |
| 3 | RANIBIZUMAB-NUNA | 1 | 0.0213 |
| 4 | VERTEPORFIN FOR INJECTION | 25 | 0.0169 |
| 5 | METHACHOLINE CHLORIDE | 1 | 0.0143 |
| 6 | PENTOSAN POLYSULFATE SODIUM | 92 | 0.0133 |
| 7 | SOY ISOFLAVONES | 1 | 0.0128 |
| 8 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 9 | INDOCYANINE GREEN | 1 | 0.0083 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 192 |
| 1 | Corticosteroid [EPC] | 178 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 96 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 50 |
| 4 | Benzodiazepine [EPC] | 42 |
| 5 | Proton Pump Inhibitor [EPC] | 42 |
| 6 | Vitamin C [EPC] | 36 |
| 7 | Insulin Analog [EPC] | 34 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 33 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 1 | Photoenhancer [EPC] | 25 | 0.0064 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 3 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 4 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 8 | 0.0018 |
| 6 | Antiseptic [EPC] | 7 | 0.0016 |
| 7 | Anticholinergic [EPC] | 23 | 0.0014 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 192 | 0.0010 |
| 9 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |